Toggle navigation
News
OK
NewsOK
News
Weather
Opinion
Business
Sports
Life
Photos
Videos
Brandinsight
Shopping
Classifieds
Homes
Jobs
Cars
Legals
Shop
Account
Settings
Subscribe
Contact Us
Support
Privacy Policy
Terms of Use
About our ads
Advertise with us
The Oklahoman
Market Watch
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Gw Pharma ADR
(NQ:
GWPH
)
135.73
USD
-2.10 (-1.52%)
Official Closing Price
Updated: 7:37 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Gw Pharma ADR
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
24
25
Next >
CBD Solid Bedrock as US Heads Back to Industrial Hemp Roots
May 24, 2018
From
CannabisNewsWire
CBD Solid Bedrock as US Heads Back to Industrial Hemp Roots
May 24, 2018
From
PR Newswire
5 Companies to Watch as Canada Legalizes Cannabis
May 21, 2018
FN Media Group Presents OilPrice.com News Commentary
From
PR Newswire
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences Announce Publication in The New England Journal of Medicine of a Phase 3 Study of Epidiolex® (cannabidiol oral solution) in Lennox-Gastaut
May 16, 2018
GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary...
From
GlobeNewswire News Releases
Cannabis is Fueling the Next Era of Medical Revolution
May 16, 2018
From
PR Newswire
GW Pharmaceuticals plc Reports Fiscal Second Quarter 2018 Financial Results and Operational Progress
May 08, 2018
GW Pharmaceuticals plc (NASDAQ:GWPH) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary...
From
GlobeNewswire News Releases
GW Pharmaceuticals to Present at Bank of America Merrill Lynch 2018 Health Care Conference
May 08, 2018
GW Pharmaceuticals plc (NASDAQ:GWPH) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary...
From
GlobeNewswire News Releases
Medical Cannabis Sales Projected to Increase
May 08, 2018
FinancialBuzz.com News Commentary
From
PR Newswire
Increasing Sales of Cannabis Products Projected to Have Positive Economic Effects
May 03, 2018
FinancialBuzz.com News Commentary
From
PR Newswire
GW Pharmaceuticals to Report Second Quarter Financial Results and Host Conference Call on 8 May, 2018
May 03, 2018
GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid...
From
GlobeNewswire News Releases
India Globalization: The Best of Both Worlds Approach -- CFN Media
May 01, 2018
From
NewMediaWire
India Globalization: The Best of Both Worlds Approach -- CFN Media
May 01, 2018
CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering India Globalization Capital...
From
GlobeNewswire News Releases
Innovative Cannabis Delivery Technology Boosts Discovery, Momentum in Biotech Sectors
April 24, 2018
From
PR Newswire
Trump and Schumer's Support of Marijuana Could be a Major Catalyst for These Companies
April 23, 2018
From
PR Newswire
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences Announces the Unanimous Positive Result of FDA Advisory Committee Meeting for First Plant-Based Pharmaceutical Cannabidiol Treatment for Se
April 19, 2018
GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW”, “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary...
From
GlobeNewswire News Releases
Factors of Influence in 2018, Key Indicators and Opportunity within Magic Software Enterprises, Tuniu, Visteon, Magna International, Eaton Corporation, and GW Pharmaceuticals — New Research Emphasizes
April 12, 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Magic Software Enterprises...
From
GlobeNewswire News Releases
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex® (cannabidiol oral solution) at the 2018 American Academy of Neurology Annual Meeting
April 12, 2018
Long-Term Safety and Efficacy Data in Patients with Lennox-Gastaut Syndrome and Dravet Syndrome to be Presented
From
GlobeNewswire News Releases
Celebrities Dipping Into the CBD Market
April 11, 2018
From
PR Newswire
Cannabis Product Sales are Expected to Increase as Legalization Continues to Expand
April 05, 2018
FinancialBuzz.com News Commentary
From
PR Newswire
Companies That Stand to Benefit From Record Growth in CBD Market
April 04, 2018
From
PR Newswire
Infusion of Biotechnology Into Cannabis Market Leads to Booming Growth
April 03, 2018
From
PR Newswire
Medical and Legal Cannabis Markets are Projected to Increase in Value
March 23, 2018
FinancialBuzz.com News Commentary
From
PR Newswire
PharmaCyte Biotech (OTCQB:PMCB) Is Using Cell-in-a-Box Live Cell Encapsulation Technology with Cannabinoids to Develop a Unique Therapy for Deadly Forms of Cancer
March 22, 2018
From
ReleaseWire - Latest Press Releases
Positive CBD Legislation Will Positively Impact These Companies
March 21, 2018
From
PR Newswire
Ontario Moves Ahead With Plan to License Cannabis Lounges
March 21, 2018
From
PR Newswire
Report: Developing Opportunities within Capital Product Partners, Adient, Arbutus Biopharma, GW Pharmaceuticals, Customers, and Laureate Education — Future Expectations, Projections Moving into 2018
March 16, 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Capital Product Partners...
From
GlobeNewswire News Releases
GW Pharmaceuticals Announces Receipt of Notices of Allowance by the United States Patent and Trademark Office (USPTO) for Five New Epidiolex® (cannabidiol) Patents
March 13, 2018
GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary...
From
GlobeNewswire News Releases
Data Shows that the Global Legal Cannabis Market is Set to Increase in Value
March 13, 2018
FinancialBuzz.com News Commentary
From
PR Newswire
Data Shows that Medical Cannabis Sales are set to Rise
March 09, 2018
FinancialBuzz.com News Commentary
From
PR Newswire
GW Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference on 12 March
March 05, 2018
GW Pharmaceuticals plc (NASDAQ:GWPH) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary...
From
GlobeNewswire News Releases
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.